Annual report
9470.TEDINET S100XBI1
Period2024-10-01 → 2025-09-30
Filed2025-12-18
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Amended by S100XKOH (2026-02-13).
Key figures · 158
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥199.1bn | 2024-10-01 → 2025-09-30 | Cons. | Net sales |
| Revenue | ¥185.6bn | 2023-10-01 → 2024-09-30 | Cons. | Net sales |
| Revenue | ¥164.1bn | 2022-10-01 → 2023-09-30v | Cons. | Net sales (5-year summary) |
| Revenue | ¥156.0bn | 2021-10-01 → 2022-09-30v | Cons. | Net sales (5-year summary) |
| Revenue | ¥150.3bn | 2020-10-01 → 2021-09-30d | Cons. | Net sales (5-year summary) |
| Operating income | ¥8.2bn | 2024-10-01 → 2025-09-30 | Cons. | Operating income |
| Operating income | ¥6.9bn | 2023-10-01 → 2024-09-30 | Cons. | Operating income |
| Ordinary income | ¥7.8bn | 2024-10-01 → 2025-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥6.9bn | 2023-10-01 → 2024-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥6.5bn | 2022-10-01 → 2023-09-30v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥6.9bn | 2021-10-01 → 2022-09-30v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥6.1bn | 2020-10-01 → 2021-09-30d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥8.8bn | 2024-10-01 → 2025-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥5.6bn | 2023-10-01 → 2024-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥3.6bn | 2024-10-01 → 2025-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥2.3bn | 2023-10-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥3.2bn | 2022-10-01 → 2023-09-30v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥3.4bn | 2021-10-01 → 2022-09-30v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥2.6bn | 2020-10-01 → 2021-09-30d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥4.7bn | 2024-10-01 → 2025-09-30 | Cons. | Profit loss |
| Net income | ¥2.7bn | 2023-10-01 → 2024-09-30 | Cons. | Profit loss |
| Total assets | ¥139.2bn | at 2025-09-30 | Cons. | Assets |
| Total assets | ¥130.7bn | at 2024-09-30 | Cons. | Assets |
| Total assets | ¥136.3bn | at 2023-09-30v | Cons. | Total assets (5-year summary) |
| Total assets | ¥123.7bn | at 2022-09-30v | Cons. | Total assets (5-year summary) |
| Total assets | ¥116.9bn | at 2021-09-30d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥79.7bn | at 2025-09-30 | Cons. | Liabilities |
| Total liabilities | ¥77.1bn | at 2024-09-30 | Cons. | Liabilities |
| Net assets / equity | ¥59.5bn | at 2025-09-30 | Cons. | Net assets |
| Net assets / equity | ¥53.7bn | at 2024-09-30 | Cons. | Net assets |
| Net assets / equity | ¥55.0bn | at 2023-09-30v | Cons. | Net assets |
| Net assets / equity | ¥48.9bn | at 2022-09-30v | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥47.4bn | at 2021-09-30d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥22.9bn | at 2025-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥20.4bn | at 2024-09-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥21.0bn | at 2025-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥18.8bn | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥19.1bn | at 2023-09-30v | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥21.7bn | at 2022-09-30v | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥18.9bn | at 2021-09-30d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥7.8bn | 2024-10-01 → 2025-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥7.2bn | 2023-10-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥5.5bn | 2022-10-01 → 2023-09-30v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥5.2bn | 2021-10-01 → 2022-09-30v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥4.4bn | 2020-10-01 → 2021-09-30d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | ¥392m | 2024-10-01 → 2025-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | ¥1.8bn | 2023-10-01 → 2024-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥4.8bn | 2022-10-01 → 2023-09-30v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥5.8bn | 2021-10-01 → 2022-09-30v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥18.1bn | 2020-10-01 → 2021-09-30d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥5.6bn | 2024-10-01 → 2025-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥9.4bn | 2023-10-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥6.2bn | 2022-10-01 → 2023-09-30v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥2.0bn | 2021-10-01 → 2022-09-30v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥7.8bn | 2020-10-01 → 2021-09-30d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥86.02 | 2024-10-01 → 2025-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥52.99 | 2023-10-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥72.51 | 2022-10-01 → 2023-09-30v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥78.67 | 2021-10-01 → 2022-09-30v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥64.55 | 2020-10-01 → 2021-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥85.49 | 2024-10-01 → 2025-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥52.6 | 2023-10-01 → 2024-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥71.9 | 2022-10-01 → 2023-09-30v | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥77.95 | 2021-10-01 → 2022-09-30v | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥63.87 | 2020-10-01 → 2021-09-30d | Cons. | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥1,241.65 | at 2025-09-30 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,219.1 | at 2024-09-30 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,195.91 | at 2023-09-30v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,102.16 | at 2022-09-30v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,079.09 | at 2021-09-30d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 36.9% | at 2025-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 39.4% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 38.7% | at 2023-09-30v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 39.2% | at 2022-09-30v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 40.2% | at 2021-09-30d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 7.0% | 2024-10-01 → 2025-09-30 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 4.3% | 2023-10-01 → 2024-09-30 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 6.3% | 2022-10-01 → 2023-09-30v | Cons. | Rate of return on equity (5-year summary) |
| ROE | 7.2% | 2021-10-01 → 2022-09-30v | Cons. | Rate of return on equity (5-year summary) |
| ROE | 6.3% | 2020-10-01 → 2021-09-30d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 10,120 | at 2025-09-30 | Cons. | Number of employees |
| Employees | 9,593 | at 2024-09-30 | Cons. | Number of employees |
| Employees | 9,490 | at 2023-09-30v | Cons. | Number of employees |
| Employees | 8,341 | at 2022-09-30v | Cons. | Number of employees |
| Employees | 7,995 | at 2021-09-30d | Cons. | Number of employees |
| Revenue | ¥8.3bn | 2024-10-01 → 2025-09-30 | Standalone | Net sales |
| Revenue | ¥7.8bn | 2023-10-01 → 2024-09-30 | Standalone | Net sales |
| Revenue | ¥7.5bn | 2022-10-01 → 2023-09-30v | Standalone | Net sales (5-year summary) |
| Revenue | ¥5.0bn | 2021-10-01 → 2022-09-30v | Standalone | Net sales (5-year summary) |
| Revenue | ¥4.6bn | 2020-10-01 → 2021-09-30d | Standalone | Net sales (5-year summary) |
| Operating income | ¥2.3bn | 2024-10-01 → 2025-09-30 | Standalone | Operating income |
| Operating income | ¥2.8bn | 2023-10-01 → 2024-09-30 | Standalone | Operating income |
| Ordinary income | ¥2.4bn | 2024-10-01 → 2025-09-30 | Standalone | Ordinary income |
| Ordinary income | ¥2.5bn | 2023-10-01 → 2024-09-30 | Standalone | Ordinary income |
| Ordinary income | ¥2.1bn | 2022-10-01 → 2023-09-30v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥450m | 2021-10-01 → 2022-09-30v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥16m | 2020-10-01 → 2021-09-30d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥2.3bn | 2024-10-01 → 2025-09-30 | Standalone | Income before income taxes |
| Profit before tax | ¥1.4bn | 2023-10-01 → 2024-09-30 | Standalone | Income before income taxes |
| Net income | ¥2.5bn | 2024-10-01 → 2025-09-30 | Standalone | Profit loss |
| Net income | ¥2.0bn | 2023-10-01 → 2024-09-30 | Standalone | Profit loss |
| Net income | ¥1.5bn | 2022-10-01 → 2023-09-30v | Standalone | Net income loss (5-year summary) |
| Net income | ¥60m | 2021-10-01 → 2022-09-30v | Standalone | Net income loss (5-year summary) |
| Net income | ¥330m | 2020-10-01 → 2021-09-30d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥80.3bn | at 2025-09-30 | Standalone | Assets |
| Total assets | ¥78.1bn | at 2024-09-30 | Standalone | Assets |
| Total assets | ¥86.2bn | at 2023-09-30v | Standalone | Total assets (5-year summary) |
| Total assets | ¥78.5bn | at 2022-09-30v | Standalone | Total assets (5-year summary) |
| Total assets | ¥76.4bn | at 2021-09-30d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥42.2bn | at 2025-09-30 | Standalone | Liabilities |
| Total liabilities | ¥40.5bn | at 2024-09-30 | Standalone | Liabilities |
| Net assets / equity | ¥38.1bn | at 2025-09-30 | Standalone | Net assets |
| Net assets / equity | ¥37.5bn | at 2024-09-30 | Standalone | Net assets |
| Net assets / equity | ¥38.8bn | at 2023-09-30v | Standalone | Net assets |
| Net assets / equity | ¥37.0bn | at 2022-09-30v | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥38.5bn | at 2021-09-30d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥821m | at 2025-09-30 | Standalone | Cash and deposits |
| Cash and deposits | ¥1.6bn | at 2024-09-30 | Standalone | Cash and deposits |
| EPS (basic) | ¥60.66 | 2024-10-01 → 2025-09-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥46.64 | 2023-10-01 → 2024-09-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥33.8 | 2022-10-01 → 2023-09-30v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥1.38 | 2021-10-01 → 2022-09-30v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥8.14 | 2020-10-01 → 2021-09-30d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥60.29 | 2024-10-01 → 2025-09-30 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥46.3 | 2023-10-01 → 2024-09-30 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥33.51 | 2022-10-01 → 2023-09-30v | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥1.36 | 2021-10-01 → 2022-09-30v | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥8.05 | 2020-10-01 → 2021-09-30d | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥26 | 2024-10-01 → 2025-09-30 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥25 | 2023-10-01 → 2024-09-30 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥25 | 2022-10-01 → 2023-09-30v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥24 | 2021-10-01 → 2022-09-30v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥22 | 2020-10-01 → 2021-09-30d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥915.22 | at 2025-09-30 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥884.19 | at 2024-09-30 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥873.49 | at 2023-09-30v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥836.74 | at 2022-09-30v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥879 | at 2021-09-30d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 47.2% | at 2025-09-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 47.8% | at 2024-09-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 44.7% | at 2023-09-30v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 46.8% | at 2022-09-30v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 50.1% | at 2021-09-30d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 6.7% | 2024-10-01 → 2025-09-30 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 5.2% | 2023-10-01 → 2024-09-30 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 4.0% | 2022-10-01 → 2023-09-30v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 0.2% | 2021-10-01 → 2022-09-30v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 1.0% | 2020-10-01 → 2021-09-30d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 44,633,232 | at 2025-09-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 44,633,232 | at 2024-09-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 44,633,232 | at 2023-09-30v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 44,633,232 | at 2022-09-30v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 44,633,232 | at 2021-09-30d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 85 | at 2025-09-30 | Standalone | Number of employees |
| Employees | 67 | at 2024-09-30 | Standalone | Number of employees |
| Employees | 60 | at 2023-09-30v | Standalone | Number of employees |
| Employees | 58 | at 2022-09-30v | Standalone | Number of employees |
| Employees | 57 | at 2021-09-30d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 85
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | capex | 2024-10-01 → 2025-09-30 | ¥7.7bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | depreciation | 2024-10-01 → 2025-09-30 | ¥688m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | employees | at 2025-09-30 | 945 pure |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2024-10-01 → 2025-09-30 | ¥16.5bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2024-10-01 → 2025-09-30 | ¥8.6bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2024-10-01 → 2025-09-30 | ¥7.9bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment assets | at 2025-09-30 | ¥18.5bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2024-10-01 → 2025-09-30 | ¥1.2bn |
| Reconciling Itemsreconciling | capex | 2024-10-01 → 2025-09-30 | ¥31m |
| Reconciling Itemsreconciling | depreciation | 2024-10-01 → 2025-09-30 | ¥51m |
| Reconciling Itemsreconciling | revenue | 2024-10-01 → 2025-09-30 | −¥8.3bn |
| Reconciling Itemsreconciling | revenue intersegment | 2024-10-01 → 2025-09-30 | −¥8.3bn |
| Reconciling Itemsreconciling | segment assets | at 2025-09-30 | ¥19.6bn |
| Reconciling Itemsreconciling | segment profit | 2024-10-01 → 2025-09-30 | −¥2.2bn |
| Educationreportable segment | capex | 2024-10-01 → 2025-09-30 | ¥1.7bn |
| Educationreportable segment | depreciation | 2024-10-01 → 2025-09-30 | ¥1.8bn |
| Educationreportable segment | employees | at 2025-09-30 | 3272 pure |
| Educationreportable segment | revenue | 2024-10-01 → 2025-09-30 | ¥95.7bn |
| Educationreportable segment | revenue external | 2024-10-01 → 2025-09-30 | ¥95.4bn |
| Educationreportable segment | revenue intersegment | 2024-10-01 → 2025-09-30 | ¥335m |
| Educationreportable segment | segment assets | at 2025-09-30 | ¥61.4bn |
| Educationreportable segment | segment profit | 2024-10-01 → 2025-09-30 | ¥5.0bn |
| Medical Welfarereportable segment | capex | 2024-10-01 → 2025-09-30 | ¥1.0bn |
| Medical Welfarereportable segment | depreciation | 2024-10-01 → 2025-09-30 | ¥939m |
| Medical Welfarereportable segment | employees | at 2025-09-30 | 5818 pure |
| Medical Welfarereportable segment | revenue | 2024-10-01 → 2025-09-30 | ¥95.2bn |
| Medical Welfarereportable segment | revenue external | 2024-10-01 → 2025-09-30 | ¥95.1bn |
| Medical Welfarereportable segment | revenue intersegment | 2024-10-01 → 2025-09-30 | ¥103m |
| Medical Welfarereportable segment | segment assets | at 2025-09-30 | ¥39.7bn |
| Medical Welfarereportable segment | segment profit | 2024-10-01 → 2025-09-30 | ¥4.3bn |
| —segment total | capex | 2024-10-01 → 2025-09-30 | ¥2.7bn |
| —segment total | depreciation | 2024-10-01 → 2025-09-30 | ¥2.8bn |
| —segment total | revenue | 2024-10-01 → 2025-09-30 | ¥190.9bn |
| —segment total | revenue external | 2024-10-01 → 2025-09-30 | ¥190.5bn |
| —segment total | revenue intersegment | 2024-10-01 → 2025-09-30 | ¥438m |
| —segment total | segment assets | at 2025-09-30 | ¥101.0bn |
| —segment total | segment profit | 2024-10-01 → 2025-09-30 | ¥9.2bn |
| Total Of Reportable Segments And Otherssegment total | capex | 2024-10-01 → 2025-09-30 | ¥10.4bn |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2024-10-01 → 2025-09-30 | ¥3.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-10-01 → 2025-09-30 | ¥207.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-10-01 → 2025-09-30 | ¥199.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-10-01 → 2025-09-30 | ¥8.3bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2025-09-30 | ¥119.6bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-10-01 → 2025-09-30 | ¥10.4bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | capex | 2023-10-01 → 2024-09-30 | ¥247m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | depreciation | 2023-10-01 → 2024-09-30 | ¥248m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2023-10-01 → 2024-09-30 | ¥14.6bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2023-10-01 → 2024-09-30 | ¥6.2bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2023-10-01 → 2024-09-30 | ¥8.4bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment assets | at 2024-09-30 | ¥9.0bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-10-01 → 2024-09-30 | ¥526m |
| Reconciling Itemsreconciling | capex | 2023-10-01 → 2024-09-30 | ¥75m |
| Reconciling Itemsreconciling | depreciation | 2023-10-01 → 2024-09-30 | ¥42m |
| Reconciling Itemsreconciling | revenue | 2023-10-01 → 2024-09-30 | −¥8.8bn |
| Reconciling Itemsreconciling | revenue intersegment | 2023-10-01 → 2024-09-30 | −¥8.8bn |
| Reconciling Itemsreconciling | segment assets | at 2024-09-30 | ¥21.0bn |
| Reconciling Itemsreconciling | segment profit | 2023-10-01 → 2024-09-30 | −¥2.0bn |
| Educationreportable segment | capex | 2023-10-01 → 2024-09-30 | ¥1.6bn |
| Educationreportable segment | depreciation | 2023-10-01 → 2024-09-30 | ¥1.7bn |
| Educationreportable segment | revenue | 2023-10-01 → 2024-09-30 | ¥92.1bn |
| Educationreportable segment | revenue external | 2023-10-01 → 2024-09-30 | ¥91.9bn |
| Educationreportable segment | revenue intersegment | 2023-10-01 → 2024-09-30 | ¥267m |
| Educationreportable segment | segment assets | at 2024-09-30 | ¥58.7bn |
| Educationreportable segment | segment profit | 2023-10-01 → 2024-09-30 | ¥4.1bn |
| Medical Welfarereportable segment | capex | 2023-10-01 → 2024-09-30 | ¥2.5bn |
| Medical Welfarereportable segment | depreciation | 2023-10-01 → 2024-09-30 | ¥1.1bn |
| Medical Welfarereportable segment | revenue | 2023-10-01 → 2024-09-30 | ¥87.6bn |
| Medical Welfarereportable segment | revenue external | 2023-10-01 → 2024-09-30 | ¥87.5bn |
| Medical Welfarereportable segment | revenue intersegment | 2023-10-01 → 2024-09-30 | ¥90m |
| Medical Welfarereportable segment | segment assets | at 2024-09-30 | ¥42.0bn |
| Medical Welfarereportable segment | segment profit | 2023-10-01 → 2024-09-30 | ¥4.2bn |
| —segment total | capex | 2023-10-01 → 2024-09-30 | ¥4.0bn |
| —segment total | depreciation | 2023-10-01 → 2024-09-30 | ¥2.8bn |
| —segment total | revenue | 2023-10-01 → 2024-09-30 | ¥179.8bn |
| —segment total | revenue external | 2023-10-01 → 2024-09-30 | ¥179.4bn |
| —segment total | revenue intersegment | 2023-10-01 → 2024-09-30 | ¥357m |
| —segment total | segment assets | at 2024-09-30 | ¥100.7bn |
| —segment total | segment profit | 2023-10-01 → 2024-09-30 | ¥8.3bn |
| Total Of Reportable Segments And Otherssegment total | capex | 2023-10-01 → 2024-09-30 | ¥4.3bn |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2023-10-01 → 2024-09-30 | ¥3.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-10-01 → 2024-09-30 | ¥194.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-10-01 → 2024-09-30 | ¥185.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-10-01 → 2024-09-30 | ¥8.8bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2024-09-30 | ¥109.7bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-10-01 → 2024-09-30 | ¥8.9bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,992
| Item | Context | Value | Unit |
|---|---|---|---|
| Number of shares held | CurrentYearInstant_No4MajorShareholdersMember | 1202000 | |
| Shareholding ratio | CurrentYearInstant_No4MajorShareholdersMember | 0.0290 | |
| Number of shares held | CurrentYearInstant_No5MajorShareholdersMember | 1200000 | |
| Shareholding ratio | CurrentYearInstant_No5MajorShareholdersMember | 0.0289 | |
| Number of shares held | CurrentYearInstant_No6MajorShareholdersMember | 994000 | |
| Shareholding ratio | CurrentYearInstant_No6MajorShareholdersMember | 0.0240 | |
| Number of shares held | CurrentYearInstant_No7MajorShareholdersMember | 948000 | |
| Shareholding ratio | CurrentYearInstant_No7MajorShareholdersMember | 0.0228 | |
| Number of shares held | CurrentYearInstant_No8MajorShareholdersMember | 913000 | |
| Shareholding ratio | CurrentYearInstant_No8MajorShareholdersMember | 0.0220 | |
| Number of shares held | CurrentYearInstant_No9MajorShareholdersMember | 793000 | |
| Shareholding ratio | CurrentYearInstant_No9MajorShareholdersMember | 0.0191 | |
| Number of shares held | CurrentYearInstant_No10MajorShareholdersMember | 689000 | |
| Shareholding ratio | CurrentYearInstant_No10MajorShareholdersMember | 0.0166 | |
| Number of shares held | CurrentYearInstant | 18060000 | |
| Shareholding ratio | CurrentYearInstant | 0.4360 | |
| Number of shares issued shares voting rights | CurrentYearInstant_SharesWithNoVotingRightsMember | － | |
| Number of shares issued shares voting rights | CurrentYearInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Number of shares issued shares voting rights | CurrentYearInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of voting rights issued shares voting rights | CurrentYearInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of shares issued shares voting rights | CurrentYearInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember | 3217100 | |
| Number of voting rights issued shares voting rights | CurrentYearInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 413387 | |
| Number of shares issued shares voting rights | CurrentYearInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 41338700 | |
| Number of shares issued shares voting rights | CurrentYearInstant_OrdinarySharesSharesLessThanOneUnitMember | 77432 | |
| Number of shares issued shares voting rights | CurrentYearInstant | 44633232 | |
| Number of voting rights issued shares voting rights | CurrentYearInstant | 413387 | |
| Number of shares held in own name treasury shares etc | CurrentYearInstant_Row1Member | 3217100 | |
| Number of shares held in others names treasury shares etc | CurrentYearInstant_Row1Member | － | |
| Total number of shares held treasury shares etc | CurrentYearInstant_Row1Member | 3217100 | |
| Shareholding ratio treasury shares etc | CurrentYearInstant_Row1Member | 0.0720 | |
| Number of shares held in own name treasury shares etc | CurrentYearInstant | 3217100 | |
| Number of shares held in others names treasury shares etc | CurrentYearInstant | － | |
| Total number of shares held treasury shares etc | CurrentYearInstant | 3217100 | |
| Shareholding ratio treasury shares etc | CurrentYearInstant | 0.0720 | |
| Total amount of dividends dividends of surplus | FilingDateInstant_Row1Member | 538000000 | JPY |
| Dividend per share dividends of surplus | FilingDateInstant_Row1Member | 13.00 | |
| Total amount of dividends dividends of surplus | FilingDateInstant_Row2Member | 538000000 | JPY |
| Dividend per share dividends of surplus | FilingDateInstant_Row2Member | 13.00 | |
| Number of male directors and other officers | FilingDateInstant | 13 | |
| Number of female directors and other officers | FilingDateInstant | 3 | |
| Ratio of female directors and other officers | FilingDateInstant | 0.188 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E00707-000MiyaharaHiroakiMember | 240886 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E00707-000FukuzumiKazuhikoMember | 83508 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E00707-000KobayakawaHitoshiMember | 64697 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E00707-000AdachiYoshinobuMember | 36427 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E00707-000GoroumaruToruMember | 31913 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E00707-000MomotaKenjiMember | 26320 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E00707-000YamamotoNorioMember | 32116 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E00707-000HosoyaHitoshiMember | 22641 | |
| Number of shares held ordinary shares information about directors and corporate auditors | FilingDateInstant_jpcrp030000-asr_E00707-000YamadaNoriakiMember | － |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |